COMMUNIQUÉS West-GlobeNewswire

AB Science présente de nouvelles données positives de son étude de phase 3 dans la mastocytose systémique sévère au 22ème Congrès international de de l'Association Européenne d'Hématologie (AEH)

22/06/2017 - 17:41

Paris, 22 juin, 17h45 AB Science présente de nouvelles données positives de son étude de phase 3 dans la mastocytose systémique sévère au 22ème Congrès international de de l'Association Européenne d'Hématologie (AEH) Le [...]

AB Science Presents Supportive Data from its Phase 3 Study in Severe Systemic Mastocytosis at the 22nd Congress of the European Hematology Association (EHA)

22/06/2017 - 17:41

Paris, June 22, 2017, 5.45pm AB Science Presents Supportive Data from its Phase 3 Study in Severe Systemic Mastocytosis at the 22 nd Congress of the European Hematology Association (EHA) Abstract Selected for [...]

Minerva Announces Completion of Bridging Study to Select Improved Formulation of MIN-101 for Use in Phase 3 Trial for the Treatment of Negative Symptoms in Patients With Schizophrenia

22/06/2017 - 14:30

New formulation observed to improve safety margin while offering bioequivalent exposure to prior formulation Company to proceed with initiation of Phase 3 trial on schedule in second half of 2017 CMC scale-up work for [...]

Auris Medical to Host Scientific Symposium at IFOS ENT World Congress in Paris

22/06/2017 - 14:00

Zug, Switzerland, June 22, 2017 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced [...]

Oriola Corporation has rearranged its long-term revolving credit facility and term loan agreement

22/06/2017 - 14:00

Oriola Corporation Stock Exchange Release 22 June 2017 at 15.00 Oriola Corporation has rearranged its long-term revolving credit facility and term loan agreement Oriola Corporation has agreed to rearrange its long-term [...]

Summit Presents Data from Phase 1 Clinical Programme of Ezutromid at the EPNS Congress

22/06/2017 - 13:00

Summit Therapeutics plc ('Summit', or 'the Company') SUMMIT PRESENTS DATA FROM PHASE 1 CLINICAL PROGRAMME OF EZUTROMID AT THE EUROPEAN PAEDIATRIC NEUROLOGY SOCIETY CONGRESS Oxford, UK, 22 June 2017 - Summit Therapeutics [...]

Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs

22/06/2017 - 13:00

LONDON, June 22, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

UPM launches a new, economical solution for the thin print market

22/06/2017 - 13:00

(UPM, Helsinki, 22 June 2017 at 14:00 EET) - The Biofore company UPM has launched a new solution for the thin print market. The revolutionary paper, UPM EcoLite, has been specially designed to meet the needs of [...]

UPM propose une nouvelle solution économique pour le marché des papiers minces

22/06/2017 - 13:00

(UPM, Helsinki, 22 juin 2017, 14h00 EET) - Le fabricant de papier UPM lance une nouvelle solution pour le marché des papiers minces. Ce papier révolutionnaire, UPM EcoLite, a été spécialement conçu pour répondre aux [...]

Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA

22/06/2017 - 11:13

Reference is made to the stock exchange notice of 14 June 2017 regarding increase of the share capital in Targovax ASA (the "Company") relating to exercise of employee options and settlement of restricted stock units. [...]

Phase 2a trial results support development of dasiglucagon in the iLet pump system for type 1 diabetes

22/06/2017 - 08:47

Dasiglucagon* is a potential first-in-class glucagon analog for prevention and treatment of low blood sugar in type 1 diabetes using an automated pump system Dasiglucagon was dosed using the iLet (TM) platform, a state- [...]

Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development

22/06/2017 - 08:00

Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development Herantis Pharma Plc Company release 22 June 2017 at 9:00 am Herantis Pharma Plc's ("Herantis [...]

Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack

22/06/2017 - 07:15

Phase III CANTOS study met the primary endpoint, a composite of heart attack, stroke and cardiovascular death, showing that ACZ885 (canakinumab) in combination with standard of care therapy reduces cardiovascular risk [...]

Santhera's Raxone® Receives First Positive EAMS Scientific Opinion from UK's MHRA in Duchenne Muscular Dystrophy

22/06/2017 - 07:00

Liestal, Switzerland, June 22, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted Raxone (idebenone) a positive scientific opinion [...]

HalioDx receives CLIA Compliance for Immunoscore® Colon

21/06/2017 - 17:00

HalioDx receives CLIA Compliance for Immunoscore® Colon HalioDx received CMS [1] CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a [...]

Mithra Pharmaceuticals: MITHRA SUCCESSFULLY RAISES €26.1 MILLION

21/06/2017 - 14:59

NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL PRESS RELEASE REGULATED INFORMATION - INSIDE [...]

Amer Sports half-year 2017 financial report published on July 27

21/06/2017 - 13:15

Amer Sports Corporation STOCK EXCHANGE RELEASE June 21, 2017 at 2:15 p.m. Amer Sports half-year 2017 financial report published on July 27 Amer Sports Corporation will publish its half-year financial report 2017 on [...]

Hemcheck Sweden AB: Presents results from user tests at Karlstad Central Hospital

21/06/2017 - 09:00

Hemcheck Sweden AB (publ) presents results from user tests at Karlstad Central Hospital hemCheck, a medical technology company addressing the issue of hemolysis, announces results from user tests at Karlstad Central [...]

A study of elite athletes shows that ColdZyme provides protection as evidenced by fewer sick days and lost training days, as well as improved quality of life

21/06/2017 - 08:35

News Enzymatica Study Elite Athletes Eng 170621 This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they [...]